A platform for research: civil engineering, architecture and urbanism
A platform for research: civil engineering, architecture and urbanism
Nation-Wide Wastewater-Based Epidemiology Assessment of Metformin Usage in China: 2014–2020
https://orcid.org/0000-0002-6456-0926
https://orcid.org/0000-0003-3756-7089
https://orcid.org/0000-0002-6873-3732
https://orcid.org/0000-0002-3162-5068
https://orcid.org/0000-0003-0042-3057
Metformin, the unique first choice medicine for type 2 diabetes (T2D) in the US and Europe, was not widely adopted in China until recently. We measured metformin in wastewater samples, collected in major cities in China every 2 years from 2014 to 2020, to understand spatial and temporal trends of metformin use in T2D treatment in China. The estimated metformin use (mg/day/person) increased significantly from 1.6 ± 1.8 in 2014 to 4.2 ± 3.6 in 2016, then to 7.0 ± 8.8 in 2018, and 9.2 ± 9.0 in 2020. Metformin use increased nationally and in all seven geographical regions. Our findings reflect the broader uptake of metformin for treatment of T2D in China in accordance with expert recommendations. There was higher metformin use in the North than in the South of China, reflecting similar spatial trends in obesity rate in China. Wastewater analysis is likely to be a cost-effective way to monitor T2D treatment across China in the future.
Wastewater analysis is used to find an increasing metformin use with geographical difference across China from 2014 to 2020.
Nation-Wide Wastewater-Based Epidemiology Assessment of Metformin Usage in China: 2014–2020
https://orcid.org/0000-0002-6456-0926
https://orcid.org/0000-0003-3756-7089
https://orcid.org/0000-0002-6873-3732
https://orcid.org/0000-0002-3162-5068
https://orcid.org/0000-0003-0042-3057
Metformin, the unique first choice medicine for type 2 diabetes (T2D) in the US and Europe, was not widely adopted in China until recently. We measured metformin in wastewater samples, collected in major cities in China every 2 years from 2014 to 2020, to understand spatial and temporal trends of metformin use in T2D treatment in China. The estimated metformin use (mg/day/person) increased significantly from 1.6 ± 1.8 in 2014 to 4.2 ± 3.6 in 2016, then to 7.0 ± 8.8 in 2018, and 9.2 ± 9.0 in 2020. Metformin use increased nationally and in all seven geographical regions. Our findings reflect the broader uptake of metformin for treatment of T2D in China in accordance with expert recommendations. There was higher metformin use in the North than in the South of China, reflecting similar spatial trends in obesity rate in China. Wastewater analysis is likely to be a cost-effective way to monitor T2D treatment across China in the future.
Wastewater analysis is used to find an increasing metformin use with geographical difference across China from 2014 to 2020.
Nation-Wide Wastewater-Based Epidemiology Assessment of Metformin Usage in China: 2014–2020
https://orcid.org/0000-0002-6456-0926
https://orcid.org/0000-0003-3756-7089
https://orcid.org/0000-0002-6873-3732
https://orcid.org/0000-0002-3162-5068
https://orcid.org/0000-0003-0042-3057
Metformin, the unique first choice medicine for type 2 diabetes (T2D) in the US and Europe, was not widely adopted in China until recently. We measured metformin in wastewater samples, collected in major cities in China every 2 years from 2014 to 2020, to understand spatial and temporal trends of metformin use in T2D treatment in China. The estimated metformin use (mg/day/person) increased significantly from 1.6 ± 1.8 in 2014 to 4.2 ± 3.6 in 2016, then to 7.0 ± 8.8 in 2018, and 9.2 ± 9.0 in 2020. Metformin use increased nationally and in all seven geographical regions. Our findings reflect the broader uptake of metformin for treatment of T2D in China in accordance with expert recommendations. There was higher metformin use in the North than in the South of China, reflecting similar spatial trends in obesity rate in China. Wastewater analysis is likely to be a cost-effective way to monitor T2D treatment across China in the future.
Wastewater analysis is used to find an increasing metformin use with geographical difference across China from 2014 to 2020.
Nation-Wide Wastewater-Based Epidemiology Assessment of Metformin Usage in China: 2014–2020
Zheng, Qiuda (author) / Du, Peng (author) / Wang, Zhe (author) / Zhang, Lingrong (author) / Zhu, Zhu (author) / Huang, Jingjing (author) / Wang, Zhenglu (author) / Hall, Wayne (author) / Dang, Anh Kim (author) / Wang, Degao (author)
ACS ES&T Water ; 3 ; 195-202
2023-01-13
Article (Journal)
Electronic Resource
English
A nationwide wastewater-based assessment of metformin consumption across Australia
| DOAJ | 2022
| DOAJ | 2023
A world of wastewater-based epidemiology
| Springer Verlag | 2023
The potential of wastewater-based epidemiology
Springer Verlag | 2023